BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Eli Lilly Partners with JD.com to Expand Weight-Loss Drug Sales in China
Eli Lilly Partners with JD.com to Expand Weight-Loss Drug Sales in China
16
2
BTCCSquare news:
Pharmaceutical giant Eli Lilly has forged a strategic alliance with JD.com's healthcare subsidiary, JD Health, to distribute its weight-loss and diabetes medications in China. The collaboration will leverage JD Health's digital platform to provide end-to-end chronic disease management services, including prescription fulfillment and long-term care.
China's vast market of 1.4 billion people presents a significant opportunity, with an estimated 148 million adults suffering from Type 2 diabetes and over 500 million classified as overweight or obese. The partnership aims to streamline access to Eli Lilly's Zepbound and Mounjaro treatments through online consultations and doorstep delivery.
By:
